GRDN insider filings
Guardian Pharmacy Services, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-09-28. Screen GRDN transaction legs live →
Insider transaction summary — last 90 days
2026-07-10 to 2026-10-08, from the filings listed below: 16 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 34.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Ackerman John — Director | 1 | — | — | 4 |
| BINDLEY WILLIAM E — Director, 10% owner | 1 | — | — | 2 |
| Bindley Capital Partners I, LLC — 10% owner | 1 | — | — | 2 |
| Burke Fred — See Remarks, Director | 1 | — | — | 2 |
| Cardinal Equity Fund, L.P. | 1 | — | — | 2 |
| Crisafulli Chris — See Remarks | 1 | — | — | 2 |
| Eakins Richard — Senior Vice President, Sales | 1 | — | — | 2 |
| Forbes Kendall | 1 | — | — | 2 |
| Martin David Norman — See Remarks | 1 | — | — | 2 |
| Morris David K — See Remarks, Director | 1 | — | — | 2 |
+6 more insiders in the window, not shown — every filing appears in the table below.
Recent insider filings — Guardian Pharmacy Services, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-28 | 4 | Towns Douglas — See Remarks | Option exercise (M): 23,450 · Option exercise (M): 23,450 (derivative) | EDGAR |
| 2026-09-28 | 4 | Bindley Capital Partners I, LLC — 10% owner | Option exercise (M): 6,100,175 · Option exercise (M): 6,100,175 (derivative) | EDGAR |
| 2026-09-28 | 4 | Cardinal Equity Fund, L.P. | Option exercise (M): 471,057 · Option exercise (M): 471,057 (derivative) | EDGAR |
| 2026-09-28 | 4 | Eakins Richard — Senior Vice President, Sales | Option exercise (M): 36,052 · Option exercise (M): 36,052 (derivative) | EDGAR |
| 2026-09-28 | 4 | Crisafulli Chris — See Remarks | Option exercise (M): 18,931 · Option exercise (M): 18,931 (derivative) | EDGAR |
| 2026-09-28 | 4 | Morris David K — See Remarks, Director | Option exercise (M): 641,870 · Option exercise (M): 641,870 (derivative) | EDGAR |
| 2026-09-28 | 4 | BINDLEY WILLIAM E — Director, 10% owner | Option exercise (M): 6,100,175 · Option exercise (M): 6,100,175 (derivative) | EDGAR |
| 2026-09-28 | 4 | Forbes Kendall | Option exercise (M): 608,570 · Option exercise (M): 608,570 (derivative) | EDGAR |
| 2026-09-28 | 4 | Tuch Jeffrey — See Remarks | Option exercise (M): 55,578 · Option exercise (M): 55,578 (derivative) | EDGAR |
| 2026-09-28 | 4 | Burke Fred — See Remarks, Director | Option exercise (M): 1,298,825 · Option exercise (M): 1,298,825 (derivative) | EDGAR |
| 2026-09-28 | 4 | Pharmacy Investors, LLC | Option exercise (M): 1,413,939 · Option exercise (M): 1,413,939 (derivative) | EDGAR |
| 2026-09-28 | 4 | Martin David Norman — See Remarks | Option exercise (M): 39,865 · Option exercise (M): 39,865 (derivative) | EDGAR |
| 2026-09-28 | 4 | Salentine Thomas J Jr — Director, 10% owner | Option exercise (M): 6,100,175 · Option exercise (M): 6,100,175 (derivative) | EDGAR |
| 2026-09-28 | 4 | Ackerman John — Director | Option exercise (M): 1,413,939 · Option exercise (M): 471,057 · Option exercise (M): 1,413,939 (derivative) · Option exercise (M): 471,057 (derivative) | EDGAR |
| 2026-09-28 | 4 | Weir Robert — See Remarks | Option exercise (M): 23,450 · Option exercise (M): 23,450 (derivative) | EDGAR |
| 2026-09-28 | 4 | Mudd William Franklin — See Remarks | Option exercise (M): 38,282 · Option exercise (M): 38,282 (derivative) | EDGAR |
| 2026-05-07 | 4 | Patchett Mary Sue — Director | Grant/award (A): 4,028 @ $0 | EDGAR |
| 2026-05-07 | 4 | COSLER STEVEN D — Director | Grant/award (A): 4,028 @ $0 | EDGAR |
| 2026-05-07 | 4 | LEWIS RANDALL J — Director | Grant/award (A): 4,028 @ $0 | EDGAR |
| 2026-03-31 | 4 | Pharmacy Investors, LLC | Option exercise (M): 1,413,939 · Option exercise (M): 1,413,939 (derivative) | EDGAR |
| 2026-03-31 | 4 | BINDLEY WILLIAM E — Director, 10% owner | Option exercise (M): 6,100,175 · Option exercise (M): 6,100,175 (derivative) | EDGAR |
| 2026-03-31 | 4 | Salentine Thomas J Jr — Director, 10% owner | Option exercise (M): 6,100,175 · Option exercise (M): 6,100,175 (derivative) | EDGAR |
| 2026-03-31 | 4 | Forbes Kendall — See Remarks | Option exercise (M): 608,570 · Option exercise (M): 608,570 (derivative) | EDGAR |
| 2026-03-31 | 4 | Morris David K — See Remarks, Director | Option exercise (M): 641,869 · Option exercise (M): 641,869 (derivative) | EDGAR |
| 2026-03-31 | 4 | Bindley Capital Partners I, LLC — 10% owner | Option exercise (M): 6,100,175 · Option exercise (M): 6,100,175 (derivative) | EDGAR |
| 2026-03-31 | 4 | Ackerman John — Director | Option exercise (M): 1,413,939 · Option exercise (M): 471,057 · Option exercise (M): 1,413,939 (derivative) · Option exercise (M): 471,057 (derivative) | EDGAR |
| 2026-03-31 | 4 | Burke Fred — See Remarks, Director | Option exercise (M): 1,298,826 · Option exercise (M): 1,298,826 (derivative) | EDGAR |
| 2026-03-31 | 4 | Cardinal Equity Fund, L.P. | Option exercise (M): 471,057 · Option exercise (M): 471,057 (derivative) | EDGAR |
| 2026-03-24 | 4 | Morris David K — See Remarks, Director | Sale (S): 187,855 @ $29.68 | EDGAR |
| 2026-03-24 | 4 | Pharmacy Investors, LLC | Sale (S): 827,636 @ $29.68 | EDGAR |
| 2026-03-24 | 4 | Burke Fred — See Remarks, Director | Sale (S): 671,432 @ $29.68 | EDGAR |
| 2026-03-24 | 4 | Salentine Thomas J Jr — Director, 10% owner | Sale (S): 3,570,677 @ $29.68 | EDGAR |
| 2026-03-24 | 4 | Bindley Capital Partners I, LLC — 10% owner | Sale (S): 3,570,677 @ $29.68 | EDGAR |
| 2026-03-24 | 4 | Ackerman John — Director | Sale (S): 827,636 @ $29.68 · Sale (S): 275,728 @ $29.68 | EDGAR |
| 2026-03-24 | 4 | BINDLEY WILLIAM E — Director, 10% owner | Sale (S): 3,570,677 @ $29.68 | EDGAR |
| 2026-03-24 | 4 | Forbes Kendall — See Remarks | Sale (S): 346,672 @ $29.68 | EDGAR |
| 2026-03-24 | 4 | Cardinal Equity Fund, L.P. | Sale (S): 275,728 @ $29.68 | EDGAR |
| 2026-03-03 | 4 | Morris David K — See Remarks, Director | Grant/award (A): 8,952 @ $0 | EDGAR |
| 2026-03-03 | 4 | Forbes Kendall — See Remarks | Grant/award (A): 8,952 @ $0 | EDGAR |
| 2026-02-13 | 4 | Forbes Kendall — See Remarks | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Burke Fred — See Remarks, Director | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Morris David K — See Remarks, Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-12-08 | 4 | Burke Fred — See Remarks, Director | Gift (G): 200,000 @ $0 | EDGAR |
| 2025-12-08 | 4 | Forbes Kendall — See Remarks | Gift (G): 21,500 @ $0 | EDGAR |
| 2025-12-05 | 4 | COSLER STEVEN D — Director | Purchase (P): 3,370 @ $29.61 | EDGAR |
| 2025-09-30 | 4 | BINDLEY WILLIAM E — Director, 10% owner | Option exercise (M): 6,100,176 · Option exercise (M): 6,100,176 (derivative) | EDGAR |
| 2025-09-30 | 4 | Morris David K — See Remarks, Director | Option exercise (M): 641,869 · Option exercise (M): 641,869 (derivative) | EDGAR |
| 2025-09-30 | 4 | Pharmacy Investors, LLC | Sale (S): 813,318 @ $20.16 · Sale (S): 150,998 @ $20.16 · Option exercise (M): 1,413,940 · Option exercise (M): 1,413,940 (derivative) | EDGAR |
| 2025-09-30 | 4 | Burke Fred — See Remarks, Director | Option exercise (M): 1,298,826 · Option exercise (M): 1,298,826 (derivative) | EDGAR |
| 2025-09-30 | 4 | Cardinal Equity Fund, L.P. | Sale (S): 270,958 @ $20.16 · Sale (S): 50,305 @ $20.16 · Option exercise (M): 471,057 · Option exercise (M): 471,057 (derivative) | EDGAR |
Recent 8-K events — Guardian Pharmacy Services, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-10 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-22 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-28 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-07 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-23 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-13 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=GRDN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →